A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of preeclampsia, according to a study in ...
The presence of maternal compromise or eclampsia at gestation greater than 20 weeks also necessitates delivery. In cases of chronic or mild hypertension, oral methyldopa may be administered on an ...
Pre-eclampsia impacts 3%–5% of pregnancies globally, significantly contributing to maternal and fetal complications. It typically manifests as gestational hypertension caused by placental ...